Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression.

scientific article

Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression. is …
instance of (P31):
scholarly articleQ13442814
meta-analysisQ815382

External links are
P356DOI10.1192/BJP.BP.114.160242
P698PubMed publication ID27103682

P50authorBrian HallahanQ42856863
Joseph R HibbelnQ89137357
Christopher E RamsdenQ96192437
John M. DavisQ96192440
John Paul SanGiovanniQ114678175
P2093author name stringTimothy Ryan
Ivan T Murray
Shauna Glynn
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectfatty acidQ61476
P1104number of pages10
P304page(s)192-201
P577publication date2016-04-21
P1433published inBritish Journal of PsychiatryQ4035428
P1476titleEfficacy of omega-3 highly unsaturated fatty acids in the treatment of depression
P478volume209

Reverse relations

cites work (P2860)
Q101121007Acute EPA-induced learning and memory impairment in mice is prevented by DHA
Q47761010Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: An open-label pilot trial
Q57276197Association of Use of Omega-3 Polyunsaturated Fatty Acids With Changes in Severity of Anxiety Symptoms
Q49388642Bioefficacy potential of different genotypes of walnut Juglans regia L.
Q47319941Blood fatty acid changes in healthy young Americans in response to a 10-week diet that increased n-3 and reduced n-6 fatty acid consumption: a randomised controlled trial
Q92430456Complementary therapies for clinical depression: an overview of systematic reviews
Q47557624Diet, nutrition and the ageing brain: current evidence and new directions
Q42257132Dietary fish, n-3 polyunsaturated fatty acid consumption, and depression risk in Japan: a population-based prospective cohort study.
Q50247505Dietary polyunsaturated fatty acids, brain function and mental health.
Q47569143Effects of eicosapentaenoic acid and docosahexaenoic acid on anxiety-like behavior in socially isolated rats
Q92431544Efficacy of omega-3 PUFAs in depression: A meta-analysis
Q40963212Emulsified omega-3 fatty-acids modulate the symptoms of depressive disorder in children and adolescents: a pilot study.
Q64107255Evaluation of the effect of insulin sensitivity-enhancing lifestyle- and dietary-related adjuncts on antidepressant treatment response: protocol for a systematic review and meta-analysis
Q40230630Food Insecurity and Depression Among Adults With Diabetes: Results From the National Health and Nutrition Examination Survey (NHANES).
Q58799131Food for Mood: Relevance of Nutritional Omega-3 Fatty Acids for Depression and Anxiety
Q58122230Lipidomics in Major Depressive Disorder
Q60441607Lipids and polyunsaturated fatty acid levels in deliberate self-harm: a 10-year follow-up study
Q102053954Low Omega-3 intake is associated with high rates of depression and preterm birth on the country level
Q39471285Metabolic fate of docosahexaenoic acid (DHA; 22:6n-3) in human cells: direct retroconversion of DHA to eicosapentaenoic acid (20:5n-3) dominates over elongation to tetracosahexaenoic acid (24:6n-3).
Q96172053N-3 polyunsaturated fatty acids promote astrocyte differentiation and neurotrophin production independent of cAMP in patient-derived neural stem cells
Q38873290Novel biotherapies are needed in youth mental health.
Q47221225Nuclear Factor-Kappa B and Alzheimer Disease, Unifying Genetic and Environmental Risk Factors from Cell to Humans
Q91893886Omega-3 Fatty Acids as a Treatment for Pediatric Depression. A Phase III, 36 Weeks, Multi-Center, Double-Blind, Placebo-Controlled Randomized Superiority Study
Q48340591Omega-3 Supplementation and the Neural Correlates of Negative Affect and Impulsivity: A Double-Blind, Randomized, Placebo-Controlled Trial in Midlife Adults
Q90169497Omega-3 fatty acids for the treatment of depressive disorders in children and adolescents: a meta-analysis of randomized placebo-controlled trials
Q33785212Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial.
Q38604033Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study
Q90737002Quantitation of Human Whole-Body Synthesis-Secretion Rates of Docosahexaenoic Acid and Eicosapentaenoate Acid from Circulating Unesterified α-Linolenic Acid at Steady State
Q90464891Relationship between Diet and Mental Health in a Young Adult Appalachian College Population
Q61806045Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders
Q64327441Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD)
Q93181443The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials

Search more.